Importantly, FAK activation engages downstream mitogen-activated protein kinase pathways, including the c-Jun N-terminal kinase (JNK) pathway, which plays a critical role in EMT induction, cancer stemness, invasion, and chemoresistance in PC and other solid tumors [33,47,48,49,50]. The gene discussed is PTK2; the disease is pachyonychia congenita.